End-of-day quote
Taipei Exchange
06:00:00 2024-05-30 pm EDT
|
5-day change
|
1st Jan Change
|
82.2
TWD
|
+0.61%
|
|
+0.37%
|
-5.19%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,012
|
1,681
|
1,186
|
1,144
|
1,241
|
2,190
|
Enterprise Value (EV)
1 |
664.7
|
1,164
|
771.4
|
988.1
|
1,096
|
1,942
|
P/E ratio
|
14.7
x
|
18.6
x
|
21.4
x
|
15
x
|
11
x
|
21.2
x
|
Yield
|
3.58%
|
3.25%
|
2.82%
|
4.05%
|
4.62%
|
2.39%
|
Capitalization / Revenue
|
1.67
x
|
2.54
x
|
2.35
x
|
1.59
x
|
1.56
x
|
2.66
x
|
EV / Revenue
|
1.1
x
|
1.76
x
|
1.53
x
|
1.37
x
|
1.38
x
|
2.36
x
|
EV / EBITDA
|
7.46
x
|
9.14
x
|
10.1
x
|
8.06
x
|
7.61
x
|
13.9
x
|
EV / FCF
|
11.9
x
|
17.5
x
|
-17.2
x
|
-4.36
x
|
146
x
|
16.8
x
|
FCF Yield
|
8.43%
|
5.71%
|
-5.82%
|
-23%
|
0.68%
|
5.96%
|
Price to Book
|
2.2
x
|
2.72
x
|
1.76
x
|
1.59
x
|
1.59
x
|
2.56
x
|
Nbr of stocks (in thousands)
|
22,376
|
22,491
|
25,057
|
25,057
|
25,057
|
25,264
|
Reference price
2 |
45.24
|
74.76
|
47.33
|
45.67
|
49.52
|
86.70
|
Announcement Date
|
4/25/19
|
3/31/20
|
3/3/21
|
3/1/22
|
2/24/23
|
3/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
606.3
|
661.1
|
504.4
|
721.6
|
795.5
|
824
|
EBITDA
1 |
89.04
|
127.4
|
76.31
|
122.6
|
143.9
|
139.5
|
EBIT
1 |
77.17
|
114.1
|
57.66
|
88.47
|
124.8
|
117.7
|
Operating Margin
|
12.73%
|
17.25%
|
11.43%
|
12.26%
|
15.69%
|
14.28%
|
Earnings before Tax (EBT)
1 |
80.34
|
111.7
|
62.96
|
109.2
|
142.4
|
119.7
|
Net income
1 |
69.89
|
91.08
|
56.62
|
77.24
|
115
|
103.4
|
Net margin
|
11.53%
|
13.78%
|
11.23%
|
10.7%
|
14.46%
|
12.55%
|
EPS
2 |
3.076
|
4.019
|
2.210
|
3.048
|
4.514
|
4.090
|
Free Cash Flow
1 |
56.01
|
66.41
|
-44.89
|
-226.8
|
7.495
|
115.7
|
FCF margin
|
9.24%
|
10.05%
|
-8.9%
|
-31.43%
|
0.94%
|
14.04%
|
FCF Conversion (EBITDA)
|
62.9%
|
52.14%
|
-
|
-
|
5.21%
|
82.9%
|
FCF Conversion (Net income)
|
80.15%
|
72.92%
|
-
|
-
|
6.52%
|
111.86%
|
Dividend per Share
2 |
1.619
|
2.429
|
1.333
|
1.848
|
2.286
|
2.070
|
Announcement Date
|
4/25/19
|
3/31/20
|
3/3/21
|
3/1/22
|
2/24/23
|
3/1/24
|
Fiscal Period: December |
2019 S2
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
---|
Net sales
1 |
327.7
|
-
|
220
|
189.4
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
52.8
|
-
|
24.24
|
31.17
|
Operating Margin
|
16.11%
|
-
|
11.02%
|
16.45%
|
Earnings before Tax (EBT)
1 |
47.99
|
-
|
29.14
|
25.97
|
Net income
1 |
42.56
|
34.47
|
23.31
|
18.39
|
Net margin
|
12.99%
|
-
|
10.6%
|
9.71%
|
EPS
2 |
1.876
|
1.380
|
0.9300
|
0.7100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/29/20
|
8/14/23
|
11/14/23
|
3/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
348
|
518
|
415
|
156
|
145
|
248
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
56
|
66.4
|
-44.9
|
-227
|
7.49
|
116
|
ROE (net income / shareholders' equity)
|
15.8%
|
15.7%
|
8.23%
|
11.1%
|
15.4%
|
12.7%
|
ROA (Net income/ Total Assets)
|
8.26%
|
9.31%
|
4.03%
|
6.06%
|
7.99%
|
7.03%
|
Assets
1 |
846.6
|
978.5
|
1,404
|
1,275
|
1,439
|
1,470
|
Book Value Per Share
2 |
20.60
|
27.50
|
26.90
|
28.70
|
31.20
|
33.90
|
Cash Flow per Share
2 |
14.60
|
21.70
|
14.50
|
7.730
|
7.110
|
10.80
|
Capex
1 |
25.5
|
5.19
|
29.8
|
351
|
7.52
|
4.37
|
Capex / Sales
|
4.2%
|
0.79%
|
5.9%
|
48.66%
|
0.95%
|
0.53%
|
Announcement Date
|
4/25/19
|
3/31/20
|
3/3/21
|
3/1/22
|
2/24/23
|
3/1/24
|
|
1st Jan change
|
Capi.
|
---|
| -5.19% | 63.85M | | -8.41% | 8.88B | | -1.68% | 1.39B | | -10.93% | 1.13B | | -20.27% | 837M | | +0.86% | 451M | | +0.90% | 427M | | -25.71% | 329M | | -55.34% | 328M | | -2.76% | 207M |
Medical Equipment Wholesale
|